Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-03 Purchase |
2021-08-03 4:51 pm |
IN8BIO INC. | INAB | FAIRBAIRN EMILY Transcend Partners Opportunity Fund LLC Director 10% Owner |
100,000 | $10 | $1,000,000 | 3,322,485 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-11-19 Option Award |
2021-11-23 4:38 pm |
N/A 2031-11-19 |
IN8BIO INC. | INAB | Goswami Trishna Chief Medical Officer |
250,000 | $0 | 250,000 (Direct) |
View |
| 2021-08-13 Other |
2021-08-17 8:18 pm |
N/A 2029-03-11 |
IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner |
23,275 | $0 | 23,275 (Indirect) |
View |
| 2021-08-13 Other |
2021-08-17 7:55 pm |
N/A 2029-03-11 |
IN8BIO INC. | INAB | Kreis Leslie W. Cavu Management LP Cavu Advisors LLC 10% Owner |
23,275 | $0 | 23,275 (Indirect) |
View |
Ownership |
2021-08-17 7:24 pm |
N/A 2029-03-11 |
IN8BIO INC. | INAB | Bios Equity Partners LP BP Directors LP 10% Owner |
0 | $0 | 23,275 (Indirect) |
View |
| 2021-08-03 Option Award |
2021-08-03 4:59 pm |
N/A 2031-08-03 |
IN8BIO INC. | INAB | Lamb Lawrence EVP and CSO |
22,082 | $0 | 83,582 (Direct) |
View |
| 2021-08-03 Conversion |
2021-08-03 4:57 pm |
N/A N/A |
IN8BIO INC. | INAB | Kreis Leslie W. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC 10% Owner |
12,649,578 | $0 | 359,374 (Indirect) |
View |
| 2021-08-03 Conversion |
2021-08-03 4:55 pm |
N/A N/A |
IN8BIO INC. | INAB | Ho William Tai-Wei President, CEO and CFO |
5,862 | $0 | 2,544,929 (Indirect) |
View |
| 2021-08-03 Conversion |
2021-08-03 4:53 pm |
N/A N/A |
IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Fund III LP BIOS Fund III NT LP BIOS Fund III QP LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner |
12,649,578 | $0 | 359,374 (Indirect) |
View |
| 2021-08-03 Conversion |
2021-08-03 4:51 pm |
N/A N/A |
IN8BIO INC. | INAB | FAIRBAIRN EMILY Transcend Partners Opportunity Fund LLC Director 10% Owner |
6,364,430 | $0 | 3,322,485 (Indirect) |
View |
| 2021-07-29 Option Award |
2021-08-02 9:36 pm |
N/A 2031-07-29 |
IN8BIO INC. | INAB | Whitfill Travis Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-07-29 Option Award |
2021-08-02 9:35 pm |
N/A 2031-07-29 |
IN8BIO INC. | INAB | Roemer Alan S. Director |
10,500 | $0 | 10,500 (Direct) |
View |
| 2021-07-29 Option Award |
2021-08-02 9:33 pm |
N/A 2031-07-29 |
IN8BIO INC. | INAB | McCall Patrick Chief Financial Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-07-29 Option Award |
2021-08-02 9:31 pm |
N/A 2031-07-29 |
IN8BIO INC. | INAB | Lamb Lawrence EVP and CSO |
61,500 | $0 | 61,500 (Direct) |
View |
| 2021-07-29 Option Award |
2021-08-02 9:30 pm |
N/A 2031-07-29 |
IN8BIO INC. | INAB | Ho William Tai-Wei President, CEO and CFO |
220,500 | $0 | 220,500 (Direct) |
View |
| 2021-07-29 Option Award |
2021-08-02 9:28 pm |
N/A 2031-06-30 |
IN8BIO INC. | INAB | Greenwood Luba Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-07-29 Option Award |
2021-08-02 9:27 pm |
N/A 2031-07-29 |
IN8BIO INC. | INAB | FAIRBAIRN EMILY Director 10% Owner |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-07-29 Option Award |
2021-08-02 9:23 pm |
N/A 2031-07-29 |
IN8BIO INC. | INAB | Brandt Peter C. Director |
10,500 | $0 | 10,500 (Direct) |
View |
Ownership |
2021-07-29 9:44 pm |
N/A 2029-03-11 |
IN8BIO INC. | INAB | Whitfill Travis Director |
0 | $0 | 12,775 (Direct) |
View |
Ownership |
2021-07-29 9:43 pm |
N/A N/A |
IN8BIO INC. | INAB | Roemer Alan S. Director |
0 | $0 | 255,553 (Direct) |
View |
Ownership |
2021-07-29 9:42 pm |
N/A 2031-01-31 |
IN8BIO INC. | INAB | McCall Patrick Chief Financial Officer |
0 | $0 | 188,816 (Direct) |
View |
Ownership |
2021-07-29 9:40 pm |
N/A N/A |
IN8BIO INC. | INAB | Lamb Lawrence EVP and CSO |
0 | $0 | 460,387 (Direct) |
View |
Ownership |
2021-07-29 9:39 pm |
N/A N/A |
IN8BIO INC. | INAB | Ho William Tai-Wei President, CEO and CFO |
0 | $0 | 2,727,429 (Direct) |
View |
Ownership |
2021-07-29 9:38 pm |
N/A N/A |
IN8BIO INC. | INAB | Greenwood Luba Director |
0 | $0 | 7,300 (Direct) |
View |
Ownership |
2021-07-29 9:37 pm |
N/A N/A |
IN8BIO INC. | INAB | Fletcher Aaron G.L. BIOS Fund III LP BIOS Fund III NT LP BIOS Fund III QP LP BIOS Capital Management LP BIOS Advisors GP LLC 10% Owner |
0 | $0 | 6,625,102 (Indirect) |
View |
Ownership |
2021-07-29 9:36 pm |
N/A N/A |
IN8BIO INC. | INAB | Kreis Leslie W. BIOS Fund II NT LP BIOS Fund II LP BIOS Fund II QP LP BIOS Incysus Co-Invest I LP Bios Equity Partners II LP BIOS Equity Partners III LP Cavu Management LP Cavu Advisors LLC 10% Owner |
0 | $0 | 6,625,102 (Indirect) |
View |
Ownership |
2021-07-29 9:35 pm |
N/A N/A |
IN8BIO INC. | INAB | FAIRBAIRN EMILY Transcend Partners Opportunity Fund LLC 10% Owner |
0 | $0 | 3,341,527 (Indirect) |
View |
Ownership |
2021-07-29 9:34 pm |
N/A N/A |
IN8BIO INC. | INAB | Brandt Peter C. Director |
0 | $0 | 254,721 (Indirect) |
View |
Ownership |
2021-07-29 9:33 pm |
N/A 2029-04-16 |
IN8BIO INC. | INAB | Beelen Melissa VP, Clinical Operation |
0 | $0 | 109,758 (Direct) |
View |